To address whether inhibiting ALK, ATR or a combination of both would affect cell proliferation and cell death, ALK-addicted NB cells were treated either with ALK inhibitors (crizotinib or lorlatinib) and/or BAY 1895344. This evidence concerns the gene ATR and neuroblastoma.